Anterix (ATEX) Insider Purchase: CFO Adds 50 Shares

Rhea-AI Filing Summary

Insider transaction summary: Anterix Inc. (ATEX) Chief Financial Officer Timothy Gray reported a purchase of 50 shares of the issuer's common stock on 08/19/2025 at a price of $22.07 per share. Following the purchase, Mr. Gray beneficially owns 77,022 shares in a direct capacity. The Form 4 was signed by an attorney-in-fact on 08/20/2025.

Insights

Securities Analyst

TL;DR: Officer purchased a very small number of shares; transaction is routine and not material to valuation.

The filing shows a single non-derivative purchase of 50 common shares by the Chief Financial Officer at $22.07 each, increasing direct beneficial ownership to 77,022 shares. The size of the trade (50 shares) is immaterial relative to typical share counts and does not constitute a meaningful signal about corporate strategy or financial condition. No derivative transactions, dispositions, or unusual execution details are reported.

Corporate Governance Expert

TL;DR: Compliance filing appears complete for the disclosed transaction; timing and signature are standard.

The Form 4 discloses the required information: reporting person identity, relation to issuer (CFO), transaction date, transaction code (P for purchase), number of shares acquired, price per share, and post-transaction ownership. The form is signed by an attorney-in-fact. There are no indications of amendments, planned trading programs, or indirect ownership arrangements in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gray Timothy

(Last) (First) (Middle)

3 GARRET MOUNTAIN PLAZA

SUITE 401

(Street)

WOODLAND PARK NJ 07424

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Anterix Inc. [ ATEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/19/2025		P		50	A	$22.07	77,022	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	s/ Gena L. Ashe, Attorney-in-Fact	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Anterix Inc. (ATEX) report on this Form 4?

The CFO, Timothy Gray, purchased 50 shares of Anterix common stock on 08/19/2025 at $22.07 per share.

How many Anterix (ATEX) shares does the reporting person own after the transaction?

After the reported purchase the reporting person beneficially owns 77,022 shares in a direct capacity.

What transaction code is used on the Form 4 and what does it mean?

The transaction code is "P", which indicates a purchase of shares.

Was the Form 4 signed and when was it filed?

The form shows a signature by an attorney-in-fact (s/ Gena L. Ashe) dated 08/20/2025 and reports the transaction date as 08/19/2025.

Did the filing report any derivative transactions or dispositions?

No. Table II (derivative securities) shows no entries; only the single non-derivative purchase is reported.